A Vaccine (VSV-hIFNβ-NIS) With or Without Cyclophosphamide and Combinations of Ipilimumab, Nivolumab, and Cemiplimab in Treating Relapsed or Refractory Multiple Myeloma, Acute Myeloid Leukemia or Lymphoma
Mayo Clinic
Mayo Clinic
Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine
Washington University School of Medicine
Wake Forest University Health Sciences
Stanford University
Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine
University of Nebraska
Fred Hutchinson Cancer Center
Barbara Ann Karmanos Cancer Institute
Jonsson Comprehensive Cancer Center
Barbara Ann Karmanos Cancer Institute
University of Wisconsin, Madison
University of Wisconsin, Madison
Mayo Clinic
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology
Swiss Cancer Institute
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
M.D. Anderson Cancer Center
M.D. Anderson Cancer Center
Ohio State University Comprehensive Cancer Center
Virginia Commonwealth University
Massachusetts General Hospital
Case Comprehensive Cancer Center
Ohio State University Comprehensive Cancer Center
City of Hope Medical Center
Indiana University
Ohio State University Comprehensive Cancer Center
Rutgers, The State University of New Jersey
Boston Medical Center
Fox Chase Cancer Center
Memorial Sloan Kettering Cancer Center
Memorial Sloan Kettering Cancer Center
Memorial Sloan Kettering Cancer Center
City of Hope Medical Center
Northwestern University
Cancer Research UK
Vanderbilt-Ingram Cancer Center
NYU Langone Health
Roswell Park Cancer Institute
Roswell Park Cancer Institute
City of Hope Medical Center
University of Arizona
Rutgers, The State University of New Jersey